Tesla CEO Elon Musk has announced that Neuralink, his neurotechnology company, is developing an implant named Blindsight, which has shown promising results in restoring vision. This innovative technology, likened to a real-life VISOR from Star Trek, is currently working on monkeys, with Musk expressing confidence that it can cure blindness, even in individuals who were born blind, aiming to restore vision. The optimism around Neuralink's Blindsight is significant, with predictions suggesting a 62% chance that a blind person will use it to see by 2030. Neuralink is also in the process of conducting clinical human trials for its first brain implant while working on this second implant aimed at curing blindness.